December 12, 2012
The Pharmaceuticals and Medical Devices Agency (PMDA) began taking public comments on proposed revisions of the Japanese Pharmacopoeia (JP) on December 10 based on the review results of the JP Revision Review Committee. The public is invited to comment on...read more